Search
Should You Go For This Blue Chip Stock At This Time-ALAB
| Acobull Canada Advisory Inc. |
March 27 | 2026 | ||||
| Name | Ticker | Sector/Industry | Market Cap | Risk Factor | |
Astera Labs Inc. | ALAB-NASDAQ | Semiconductor | $19.337 Billion | Medium | |
Astera Labs, Inc. develops and markets semiconductor-based connectivity solutions tailored for cloud and AI infrastructure. Its offerings include an intelligent connectivity platform featuring high-speed, mixed-signal semiconductor products that incorporate a network of microcontrollers and sensors, along with its COSMOS software suite.
Recent Highlights
|
| Fourth Quarter 2025 Financial Highlights |
| Stock Observation- The company expects continued momentum following revenue of $270.6 million, which grew 17% sequentially and 92% year over year, and anticipates sustained demand, further sequential growth, and potential margin expansion as it scales operations and capitalizes on strong market opportunities. |
|
Risk Involved- Financial performance of the company may have an impact on the company stock performance. |
| Considering all the factors and financials of the company Acrobull Canada Advisory Inc ltd. maintains Customer Choose Buy for the stock. |
Disclaimer- Though our research is fundamentally and technically based on Acrobull Canada Advisory Inc ltd only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull Canada Advisory Inc ltd. would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations. It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull Canada Advisory Inc ltd. is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull Canada Advisory Inc ltd. does not guarantee returns. |
Acrobull Recommendation Based on Evaluation
| Current Market Price | $113.61 USD |
| Acrobull Recommendation | Buy at $109.16 |
| Target Price | $127.98 USD |
| RSI Level | 14 Day RSI 34 |
| Total Shares Outstanding | 170.21 million |
Shares held by Insiders Shares Held By Institutional Investors Risk Factor Stop Loss | 11.29% 79.51% Medium 5% |
© Copyright Acro Bull UK All Rights Reserved 2026